ArticleIn vivo (Athens, Greece)

Comparison of the Efficacy of EGFR Tyrosine Kinase Inhibitors Erlotinib and Low-dose Osimertinib on a PC-9-GFP

Yuki Katsuya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.